** Shares of LBT Innovations rise as much as 73.3% to A$0.026, their highest since April 5
** Stock posts its biggest intraday pct gain since March 13
** Medical technology firm says it has signed agreement to sell five APAS Independence instruments to AstraZeneca with total contract value between $2.2 mln and $2.7 mln
** APAS Independence is an in vitro diagnostic instrument for the automated imaging, analysis and interpretation of agar culture plates
** About 9.9 mln LBT shares change hands, compared with the 30-day average volume of 1.5 mln
** Stock had risen 36.4% this year, as of last close
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.